CurrentCardio
Get Weekly

Topic · page 3 of 28

Coronary disease & ACS

Acute and chronic coronary syndromes, MI, INOCA/ANOCA, revascularisation strategy, antithrombotic therapy after ACS/PCI, chest-pain diagnostics

Briefs 81–120 of 1,104 placed here, newest publication first

Briefs in Coronary disease & ACS

Newest publication first

  1. JAMA Cardiol

    Long-Term Outcomes Following Bilateral vs Single Internal Thoracic Artery Grafts: A Secondary Analysis of a Randomized Clinical Trial

    Secondary analysis

  2. Eur Heart J Acute Cardiovasc Care

    Influences of socioeconomic and environmental factors on STEMI incidence and related mortality: insights from the Belgian Environmental Myocardial Infarction Risk (EMIR) Study

    Research article

  3. Eur Heart J Acute Cardiovasc Care

    Complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease: 10-year outcome from the DANAMI-3–PRIMULTI trial

    Secondary analysis

  4. Circulation

    Pathology of Genetic Variants in Spontaneous Coronary Artery Dissection

    Cohort study

  5. Eur J Prev Cardiol

    Medication persistence and mortality in ST-elevation myocardial infarction patients with and without standard modifiable risk factors: a SWEDEHEART registry study

    Cohort study

  6. JAMA Cardiol

    Modifiable Risk Factors and Attributable Ischemic Heart Disease Mortality in US States, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023

    Research article

  7. JACC Cardiovasc Interv

    1-Year Outcomes of Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent for Coronary Artery Bypass Graft Lesions

    Cohort study

  8. J Am Coll Cardiol

    Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome: The BRIDGE Trial

    Randomised controlled trial

  9. Heart

    Geographic variation in long-term health outcomes following myocardial infarction in England

    Cohort study

  10. Eur Heart J

    Intravenous dexrazoxane for haemorrhagic myocardial infarction: the SHIELD-MI study

    Randomised controlled trial

  11. Eur Heart J

    Patients with angina and non-obstructive coronary artery disease undergoing comprehensive invasive coronary function testing: long-term clinical outcomes

    Cohort study

  12. Eur Heart J

    Takotsubo syndrome diagnosis: the biomarker-based BioTAK score

    Diagnostic or prognostic study

  13. Am Heart J

    Clinical outcomes associated with recurrent compared to first-time myocardial infarction

    Cohort study

  14. Eur Heart J

    Antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation: an individual patient data network meta-analysis

    Meta-analysis

  15. Lancet

    Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data

    Meta-analysis

  16. Am Heart J

    Age-specific coronary outcomes in subacute Kawasaki disease

    Research article

  17. Eur Heart J Cardiovasc Imaging

    Platelet activation and thrombosis in microvascular obstruction

    Cohort study

  18. Eur J Prev Cardiol

    Women with angina and no obstructive coronary artery disease: IL-6 identifies a cardiometabolic high-risk phenotype and predicts cardiovascular events

    Cohort study

  19. JAMA Cardiol

    Causal Endotype–Based Classification of Myocardial Infarction

    Cohort study

  20. N Engl J Med

    Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain

    Randomised controlled trial

  21. N Engl J Med

    Complete Revascularization Guided by Functional Coronary Angiography in STEMI

    Randomised controlled trial

  22. Lancet

    Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial

    Randomised controlled trial

  23. J Am Coll Cardiol

    Stent Retriever Thrombectomy in Patients With Myocardial Infarction: The Open-Label, Multicenter NATURE Superiority Trial

    Randomised controlled trial

  24. Eur Heart J

    Local vs systemic inflammation and outcomes after percutaneous coronary intervention

    Cohort study

  25. Nat Med

    Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial

    Randomised controlled trial

  26. N Engl J Med

    Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients

    Randomised controlled trial

  27. N Engl J Med

    Prasugrel versus Ticagrelor in Acute Coronary Syndromes

    Randomised controlled trial

  28. N Engl J Med

    Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI

    Randomised controlled trial

  29. N Engl J Med

    Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event

    Randomised controlled trial

  30. Eur Heart J

    ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey

    Cross-sectional study

  31. JAMA

    LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: The AMUNDSEN Randomized Clinical Trial

    Randomised controlled trial

  32. Eur J Prev Cardiol

    Associations of exercise capacity after myocardial infarction with mortality and major adverse cardiovascular events: sex-specific findings from the nationwide SWEDEHEART cohort

    Cohort study

  33. Eur J Prev Cardiol

    Sex differences in statin treatment after myocardial infarction in Denmark: a time-trend study utilizing Danish national registries

    Cohort study

  34. JACC Adv

    Incidence of Dementia in Older Adults Hospitalized With Acute Coronary Syndrome: Insights From KP-Brain-Heart Health Study

    Cohort study

  35. J Am Coll Cardiol

    Bivalirudin Versus Heparin in Low and Non-Low Bleeding Risk Patients Undergoing Primary PCI for STEMI: The BRIGHT-4 Trial

    Secondary analysis

  36. J Am Coll Cardiol

    Addition of Computed Tomography–Derived Fractional Flow Reserve in the Diagnostic Pathway of Patients With Stable Coronary Artery Disease: The FUSION Randomized Controlled Trial

    Randomised controlled trial

  37. J Am Coll Cardiol

    Vericiguat for the Treatment of Coronary Vasospasm (ViVA)): A Double-Blind Placebo-Controlled Randomized Crossover Trial

    Randomised controlled trial

  38. Circulation

    Vitamin K 2 and D 3 Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE Trial

    Randomised controlled trial

  39. Eur Heart J

    Microvascular resistance reserve and cardiovascular outcomes: the FLOW-CMD registry

    Cohort study

  40. Eur J Prev Cardiol

    The DiagnOsis of MINOCA (DOMINO) registry: a real-world use of multimodality imaging and its impact on etiologic classification

    Cohort study

All 1,104 Briefs in ExploreShowing Briefs 81–120 of 1,104, newest first